Thermo Fisher Scientific Opens New Distribution Center in Ireland

Mar 8, 2026 | Biotech, News

Image Source: Thermo Fisher
Written by: Contributor
On behalf of: Life Science Daily News
70,000 sq. ft. facility expands the company’s biopharma, chemical and cold chain storage capacities
DUBLIN, Ireland, (March 6, 2026) – Thermo Fisher Scientific Inc, the world leader in serving science, today announced the opening of a new, 70,000 sq.ft. distribution center in Bracetown, County Meath, Ireland. The facility significantly expands the company’s infrastructure in Ireland, one of the world’s leading hubs for pharmaceutical and biopharmaceutical manufacturing.
The purpose-built site will increase Thermo Fisher’s in-country distribution capacity by more than 400%, enabling the supply and storage of a broader portfolio of products to support drug discovery research, clinical development and commercial manufacturing. The investment strengthens supply chain resilience for Ireland’s fast-growing life sciences sector and enhances local access to critical materials, chemicals and temperature-sensitive products. By expanding local inventory and accelerating fulfilment, the facility will help biopharma and academic organizations reduce lead times and support uninterrupted production.
The new distribution center has also been designed with sustainability and long-term energy efficiency at its core. An on-site solar system is expected to generate approximately 120,000 kWh of electricity annually. A high-efficiency heat pump enables the site to operate on 100% renewable energy. The facility has achieved an A2 Building Energy Rating (BER) reflecting its strong energy performance.
“Today’s opening reflects Thermo Fisher’s long-term commitment to serving Ireland’s vibrant life sciences sector,” said Claire Wallace, president, Research & Safety Market Division, Europe and Europe Commercial, Thermo Fisher Scientific. “By expanding our local distribution capacity, we are responding more efficiently to the needs of our customers, partnering with them to improve the quality, speed and reliability of their supply chains. The products moving through this facility support the research, development and manufacturing of therapies reaching patients around the world.”
The center was officially opened at a ribbon-cutting event attended by high-profile guests, including Minister Peter Burke TD, Minister for Enterprise, Tourism and Employment, Rory Mullen, Head of Life Sciences for Industrial Development Authority (IDA) Ireland and key customers from the life sciences industry and academia in Ireland.
“This significant investment by Thermo Fisher Scientific reinforces Ireland’s position as a global leader in life sciences and biopharmaceutical manufacturing,” said Minister Burke TD, Minister for Enterprise, Tourism and Employment. “The new distribution centre strengthens vital supply chain infrastructure and reflects continued confidence in Ireland’s scientific talent, pro-enterprise environment and long-term strategic vision to be a world-class hub for life sciences. I welcome the positive impact this expansion will have both regionally and nationally.”

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue of approximately $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit www.thermofisher.com.

Feature Image – From left to right:- Brian O’Callaghan, Suzanne Sheridan, Minister Burke TD, Claire Wallace, Gabriel Weissenbacher, Alex Ströhle

    References:

    Articles that may be of interest

    When ADHD and Menopause Overlap

    When ADHD and Menopause Overlap

    When ADHD and Menopause Overlap: Why Midlife Women Are Still Not Getting the Right Answers Girls and women have historically been overlooked in the ADHD diagnostic process and this is due, in part, to the fact that their symptoms often present differently than they do...

    read more
    How Rapid Access MRI Can Reshape Diagnostic Pathways

    How Rapid Access MRI Can Reshape Diagnostic Pathways

    It’s no secret that the National Health Service (NHS) is suffering diagnostic pressure. The British Medical Association (BMA) reports that in November 2024, approximately 1.6 million people in England were waiting for a diagnostic test. That’s double the 0.8...

    read more
    NHS England First in World to Offer Blenrep for Myeloma

    NHS England First in World to Offer Blenrep for Myeloma

    Blenrep Multiple Myeloma NHS England Rollout Makes UK a World First in Blood Cancer Treatment England has become the first country in the world to make GSK's belantamab mafodotin, marketed as Blenrep, available to multiple myeloma patients through a national health...

    read more
    Weekly News Roundup | 20 April 2026

    Weekly News Roundup | 20 April 2026

    Life science news 20 April 2026: A landmark pancreatic cancer breakthrough, record-breaking biotech IPO, major UK investment announcements and a surge in FDA approvals define a momentous week for the global life science industry. Revolution Medicines reported on 13...

    read more

    Articles that may be of interest

    When ADHD and Menopause Overlap

    When ADHD and Menopause Overlap

    When ADHD and Menopause Overlap: Why Midlife Women Are Still Not Getting the Right Answers Girls and women have historically been overlooked in the ADHD diagnostic process and this is due, in part, to the fact that their symptoms often present differently than they do...

    read more
    How Rapid Access MRI Can Reshape Diagnostic Pathways

    How Rapid Access MRI Can Reshape Diagnostic Pathways

    It’s no secret that the National Health Service (NHS) is suffering diagnostic pressure. The British Medical Association (BMA) reports that in November 2024, approximately 1.6 million people in England were waiting for a diagnostic test. That’s double the 0.8...

    read more
    NHS England First in World to Offer Blenrep for Myeloma

    NHS England First in World to Offer Blenrep for Myeloma

    Blenrep Multiple Myeloma NHS England Rollout Makes UK a World First in Blood Cancer Treatment England has become the first country in the world to make GSK's belantamab mafodotin, marketed as Blenrep, available to multiple myeloma patients through a national health...

    read more
    Weekly News Roundup | 20 April 2026

    Weekly News Roundup | 20 April 2026

    Life science news 20 April 2026: A landmark pancreatic cancer breakthrough, record-breaking biotech IPO, major UK investment announcements and a surge in FDA approvals define a momentous week for the global life science industry. Revolution Medicines reported on 13...

    read more